AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 109 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $5,000 | -28.6% | 8,000 | 0.0% | 0.00% | – |
Q3 2019 | $7,000 | 0.0% | 8,000 | -25.2% | 0.00% | – |
Q2 2019 | $7,000 | -46.2% | 10,700 | -31.8% | 0.00% | – |
Q1 2019 | $13,000 | -13.3% | 15,700 | +71.6% | 0.00% | – |
Q4 2018 | $15,000 | -55.9% | 9,150 | -11.6% | 0.00% | – |
Q3 2018 | $34,000 | +88.9% | 10,352 | +29.4% | 0.00% | – |
Q2 2018 | $18,000 | – | 8,002 | +3220.3% | 0.00% | – |
Q3 2015 | $0 | – | 241 | 0.0% | 0.00% | – |
Q2 2015 | $0 | -100.0% | 241 | -98.9% | 0.00% | – |
Q3 2013 | $45,000 | -48.9% | 22,204 | -36.6% | 0.00% | – |
Q2 2013 | $88,000 | – | 35,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deer VI & Co. LLC | 675,242 | $2,465,000 | 100.00% |
New Leaf Venture Partners, L.L.C. | 2,340,673 | $8,543,000 | 3.96% |
RA Capital Management | 11,328,646 | $41,350,000 | 3.74% |
NEA Management Company, LLC | 16,362,694 | $59,724,000 | 2.09% |
Avoro Capital Advisors LLC | 4,806,249 | $17,543,000 | 1.36% |
683 Capital Management, LLC | 2,515,810 | $9,183,000 | 0.96% |
SPHERA FUNDS MANAGEMENT LTD. | 1,400,000 | $5,110,000 | 0.73% |
Perceptive Advisors | 6,830,232 | $25,110,000 | 0.48% |
EAM Investors, LLC | 785,338 | $2,866,000 | 0.38% |
Polar Capital LLP | 4,129,238 | $15,072,000 | 0.17% |